<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00149422</url>
  </required_header>
  <id_info>
    <org_study_id>2003B131</org_study_id>
    <nct_id>NCT00149422</nct_id>
  </id_info>
  <brief_title>Effect of NT-proBNP Guided Treatment of Chronic Heart Failure</brief_title>
  <official_title>Can Pro-brain-natriuretic Peptide Guided Therapy of Chronic Heart Failure Improve Heart Failure Morbidity and Mortality?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Netherlands Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Interuniversity Cardiology Institute of the Netherlands</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Netherlands Heart Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether NT-proBNP guided treatment of chronic
      congestive heart failure will reduce heart failure related morbidity and mortality compared
      to therapy guided by standard clinical judgement.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in total number of days alive and outside the hospital between the NT-proBNP guided and the clinical guided group.</measure>
    <time_frame>minimum of one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>at least one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>at least one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause hospitalization</measure>
    <time_frame>at least one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular related hospitalization</measure>
    <time_frame>at least one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of hospitalizations and mortality</measure>
    <time_frame>at least one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of cardiovascular hospitalizations and mortality</measure>
    <time_frame>at least one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in primary and secondary outcome measures among renal function and age subgroups</measure>
    <time_frame>At least one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in evidence based heart failure medication prescription after 3, 6 and 12 months</measure>
    <time_frame>At least one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of major endpoints in patients where NT-proBNP levels were at or below the individual target level in at least 75% of all outpatient visits</measure>
    <time_frame>at least one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Heart Failure, Congestive</condition>
  <arm_group>
    <arm_group_label>NT-proBNP guided treatment group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group, management was guided by an individually set NT-proBNP, defined by the lowest level at discharge or 2 weeks thereafter. If NT-proBNP levels were elevated above the individually set NT-proBNP interventions were performed according to the ESC heart failure guidelines.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinically guided arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Heart failure treatment guided by clinical assessment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NT-proBNP measurements</intervention_name>
    <arm_group_label>NT-proBNP guided treatment group</arm_group_label>
    <arm_group_label>Clinically guided arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admission because of congestive heart failure

          -  Elevated NT-proBNP levels on admission

        Exclusion Criteria:

          -  Life-threatening cardiac arrhythmias

          -  Urgent intervention

          -  Severe lung disease

          -  Presence of life threatening disease

          -  Signed informed consent for other study

          -  Mental or physical status not allowing written informed consent.

          -  Unwillingness to give informed consent

          -  Patients undergoing haemodialysis or continuous ambulatory peritoneal dialysis (CAPD)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dave JW van Kraaij, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universtiy Hospital Maastricht</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>5800</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2005</study_first_submitted>
  <study_first_submitted_qc>September 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <last_update_submitted>February 8, 2010</last_update_submitted>
  <last_update_submitted_qc>February 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Yigal Pinto</name_title>
    <organization>Academic Medical Center, Amsterdam</organization>
  </responsible_party>
  <keyword>NT-proBNP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

